Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1CNS 1

Conditions

Zollinger-Ellison Syndrome 1Vipoma 1Tongue Neoplasms 1Stomatitis 1Somatostatinoma 1Radiation Injuries 1Prostatic Neoplasms 1Paraganglioma 1Oropharyngeal Neoplasms 1Mouth Neoplasms 1Mediastinal Neoplasms 1Laryngeal Neoplasms 1Insulinoma 1Head and Neck Neoplasms 1Glucagonoma 1Esthesioneuroblastoma, Olfactory 1Esophageal Neoplasms 1Carcinoma, Merkel Cell 1Carcinoma, Medullary 1Adenoma, Islet Cell 1

Interventions

Docetaxel 6Radiotherapy 5Filgrastim 5Cisplatin 5Etoposide 3Erlotinib Hydrochloride 3Chemotherapy, Adjuvant 3Cetuximab 3Capecitabine 3Bevacizumab 3sargramostim 2Radiotherapy, Intensity-Modulated 2Peripheral Blood Stem Cell Transplantation 2Paclitaxel 2Gemcitabine 2Carboplatin 2Acupuncture Therapy 2tumor necrosis factor-alpha, CNGRC fusion protein, human 1tanespimycin 1oncogene protein E7, Human papillomavirus type 16 1oblimersen 1etoposide phosphate 1entinostat 1cevimeline 1aldesleukin 1X-Ray Therapy 1Vorinostat 1Tomography, X-Ray Computed 1Thiotepa 1Thalidomide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Esthesioneuroblastoma, Olfactory × Salts × Clear all
NCT00293462 2021-07-30

GM-CSF Mouthwash for Preventing and Treating Mucositis in Patients Undergoing Radiation Therapy for Head and Neck Cancer

University of California, San Francisco

Phase 3 Completed
91 enrolled 16 charts
CNSHead & Neck

Head and Neck Neoplasms, Radiation Injuries, Stomatitis, Tongue Neoplasms, Esthesioneuroblastoma, Olfactory

Data powered by HemOnc (CC BY 4.0) Colophon âš¡